Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.107
H.R.107: To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Jan. 3, 2019
- Latest Major Action Jan. 25, 2019
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Version
- Introduced in House - Jan. 3, 2019
Bill Summary
This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100% of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2020.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Jan. 31, 2019 |
Referred to the Subcommittee on Health.
|
Jan. 25, 2019 |
Referred to the Subcommittee on Health.
|
Jan. 3, 2019 |
Referred to the House Committee on Energy and Commerce.
|
Jan. 3, 2019 |
Introduced in the House by Michael C. Burgess (R-Texas) |